Biodesix (BDSX) Gross Profit (2019 - 2026)
Biodesix filings provide 8 years of Gross Profit readings, the most recent being $21.3 million for Q1 2026.
- On a quarterly basis, Gross Profit rose 49.77% to $21.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $81.8 million, a 23.25% increase, with the full-year FY2025 number at $80.9 million, up 26.96% from a year prior.
- Gross Profit hit $21.3 million in Q1 2026 for Biodesix, down from $26.8 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $26.8 million in Q4 2025 to a low of $3.3 million in Q1 2022.
- Median Gross Profit over the past 5 years was $12.7 million (2024), compared with a mean of $13.0 million.
- Biggest five-year swings in Gross Profit: tumbled 68.89% in 2022 and later soared 115.2% in 2024.
- Biodesix's Gross Profit stood at $6.3 million in 2022, then soared by 79.24% to $11.3 million in 2023, then surged by 113.26% to $24.1 million in 2024, then rose by 11.24% to $26.8 million in 2025, then decreased by 20.32% to $21.3 million in 2026.
- The last three reported values for Gross Profit were $21.3 million (Q1 2026), $26.8 million (Q4 2025), and $17.7 million (Q3 2025) per Business Quant data.